Skip to content

The effect of stellate ganglion on rebound pain after femoral nerve block in arthroscopic ligament reconstruction surgery of knee

The effect of stellate ganglion on rebound pain after femoral nerve block in arthroscopic ligament reconstruction surgery of knee

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100565
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-04-18
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopic Ligament Reconstruction Surgery of Knee

Interventions

Observation group:Stellate ganglion block

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) The American Society of Anesthesiologists (ASA) classifies it as grade I-II; (2) Age range of 18 to 65 years old, gender not limited; (3) Patients undergoing anterior cruciate ligament surgery under knee arthroscopy; (4) Patients and their families provide informed consent for the study and sign the informed consent form; (5) Normal communication and exchange can be carried out.

Exclusion criteria

Exclusion criteria: (1) Individuals allergic to opioids or local anesthetics; (2) Individuals with contraindications for femoral nerve block; (3) Diabetes patients with peripheral neuropathy; (4) Those who disagree with the content of this study; (5) People with language communication difficulties or mental disorders.

Design outcomes

Primary

MeasureTime frame
Incidence of rebound pain;

Secondary

MeasureTime frame
NRS scores at various postoperative time points;The incidence of remedial analgesia, as well as the incidence, severity, and use of antiemetic drugs of PONV within 24 hours after surgery;Postoperative first night Athens Insomnia Scale (AIS) score and anesthesia satisfaction score;

Countries

China

Contacts

Public ContactLe Qi

Xuzhou Central Hospital

604867087@qq.com+86 153 6588 8019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026